Ardent Health Partners, LLC (NYSE:ARDT) Shares Sold by Woodline Partners LP

Woodline Partners LP trimmed its holdings in Ardent Health Partners, LLC (NYSE:ARDT - Free Report) by 7.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 641,046 shares of the company's stock after selling 55,128 shares during the quarter. Woodline Partners LP owned about 0.45% of Ardent Health Partners worth $10,949,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of ARDT. Point72 Asia Singapore Pte. Ltd. purchased a new position in Ardent Health Partners in the 4th quarter worth approximately $27,000. US Bancorp DE acquired a new stake in shares of Ardent Health Partners during the 4th quarter worth approximately $31,000. R Squared Ltd acquired a new stake in shares of Ardent Health Partners during the 4th quarter worth approximately $37,000. New York State Common Retirement Fund acquired a new stake in shares of Ardent Health Partners during the 4th quarter worth approximately $48,000. Finally, Deutsche Bank AG increased its holdings in shares of Ardent Health Partners by 1,251.9% during the 4th quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock worth $49,000 after buying an additional 2,654 shares during the last quarter.

Analyst Ratings Changes

A number of analysts have recently issued reports on ARDT shares. Stephens restated an "overweight" rating and set a $21.00 price target on shares of Ardent Health Partners in a report on Tuesday, May 20th. Royal Bank of Canada restated an "outperform" rating and set a $21.00 price target on shares of Ardent Health Partners in a report on Thursday, May 15th. Guggenheim raised their price target on shares of Ardent Health Partners from $16.00 to $18.00 and gave the stock a "buy" rating in a report on Friday, May 9th. Finally, Mizuho cut their price target on shares of Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Two research analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $20.67.

Ardent Health Partners Trading Down 1.7%

Ardent Health Partners stock traded down $0.26 during trading on Wednesday, hitting $14.61. The company had a trading volume of 10,706 shares, compared to its average volume of 391,133. Ardent Health Partners, LLC has a 1-year low of $11.31 and a 1-year high of $20.72. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The company's 50 day simple moving average is $13.27 and its 200-day simple moving average is $14.71. The stock has a market cap of $2.09 billion and a price-to-earnings ratio of 8.97.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.21 by $0.08. The business had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.50 billion. As a group, analysts expect that Ardent Health Partners, LLC will post 1.23 EPS for the current fiscal year.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.